MPA Meningioma Risk: Key Insights and Implications

By Crystal Lubbe

January 22, 2025

The South African Health Products Regulatory Authority (SAHPRA) has issued a clarification regarding the benefits and risks associated with medroxyprogesterone acetate (MPA), a synthetic form of the hormone progesterone. This substance is used for...
MENA Generics Biologics Healthcare Innovation
Trump Healthcare Policy Changes: Reversing Biden’s Executive Orders and...
U.S. Withdraws from WHO: Impact on Global Health Security and Relations
Advancing EU Health Technology Assessment: Insights from the HAG Meeting
Medicare Drug Negotiations Target Ozempic and Ibrance for Price Cuts
Transforming Africa through Healthcare Biotechnology Innovation
Cholera Vaccination Campaign Amid Ongoing Outbreak
Pharmaceutical Data Collaboration Between Canada’s Drug Agency and CIHI
Blueprint for Transforming Healthcare Access in Africa
Thyroid Cancer Diagnosis: Delays During the Pandemic, Implications and Trends
Cost-Effectiveness of Switching to the Nonavalent HPV Vaccine in the Netherlands
GLP-1 Receptor Agonists: Balancing Benefits and Risks in Treatment Decisions